Needham Maintains Buy on Avadel Pharmaceuticals, Raises Price Target to $22
Needham Maintains Buy on Avadel Pharmaceuticals, Raises Price Target to $22
Needham維持對Avadel Pharmicals的買入，將目標股價上調至22美元
Needham analyst Ami Fadia maintains Avadel Pharmaceuticals (NASDAQ:AVDL) with a Buy and raises the price target from $20 to $22.
尼德姆分析師阿米·法迪亞維持阿瓦德爾製藥公司（納斯達克股票代碼：AVDL）的買入並將目標股價從20美元上調至22美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。